Fetal Monitoring Market by Product (Ultrasound (3D & 4D), Fetal Electrodes, Telemetry Devices, Accessories and Consumables), Portability (Portable Systems), Method (Invasive), Application (Antepartum), End User (Hospitals) - Global Forecast to 2026
[228 Pages Report] The fetal monitoring market is projected to reach USD 5.2 billion by 2026 from USD 3.7 billion in 2021, at a CAGR of 7.2% from 2021 to 2026. The development of noninvasive, portable, and advanced fetal monitors and emerging markets and strengthening infrastructure are expected to offer growth opportunities in the market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID -19 Impact on the Fetal Monitoring Market
The coronavirus pandemic has compelled regulatory bodies, such as the FDA, to ease their regulatory norms for fetal monitors to support the uninterrupted care regime of expectant mothers. Relaxations in rules have paved the way for several key players to smoothly launch fetal monitors equipped with tele-ultrasound monitoring, noninvasive features, and portable technologies. For instance, the FDA released its updated April 2020 FDA guidance amid the pandemic, under which Philips successfully launched its fetal monitor, Avalon CL, in the US on June 12, 2020. The FDA’s enforcement policy for noninvasive fetal and maternal monitoring devices aims to increase access to devices that could reduce the need for in-clinic visits and reduce the burden on doctor’s offices and hospitals during the pandemic.
The outbreak of COVID-19 has led to various valuable partnerships among companies, which is anticipated to fuel the market's growth. For instance, in January 2021, Israel-based Nuvo Group (offering a remote pregnancy monitoring platform) entered into a commercial agreement with Axia Women’s Health, an innovative women’s health network. Under the agreement, Axia Women’s Health will be able to prescribe INVU to expectant mothers, which is expected to reduce the risk of exposure during COVID-19.
Market Dynamics
DRIVER: Advanced and innovative fetal monitoring technologies
The fetal monitoring market is expanding with the latest innovative technologies, backed by escalating research and product launches. Fetal monitoring technologies are now being streamlined to provide greater assistance in utero fetal surgeries, consisting of challenging physical fetal access and technological complications. Fetal cardiac assessments have also witnessed progress that supports high-fidelity hemodynamic and continuous physiologic monitoring, thus enabling early diagnosis and treatment.
Computer-Aided Decision Support Systems and Artificial Intelligence (AI) are also utilized in continuous cardiotocography (CTG) or fetal heart rate (FHR) auscultation during labor. The patient’s electronic health records (EHRs) are utilized along with computational methods, machine learning, and deep learning tools.
Research and technological advancements in fetal monitoring systems have increased focus on noninvasive monitoring procedures. Obstetrics has been introduced with noninvasive diagnosis technologies such as Doppler studies, cell-free fetal DNA assessment, electronic fetal monitoring (EFM), and fetal acid-base status. Fetal and neonatal assessments are carried out during antepartum via percutaneous umbilical cord blood sampling and during intrapartum with fetal scalp blood sampling immediately after birth. Fetal phonocardiography has been integrated with advanced data acquisition systems and databases. Progressing data analytics, synthetic data generation by advanced mathematical models, and classifications & processing algorithms are under active research & development to increase fetal motoring data processing efficacy.
RESTRAINTS: High cost of fetal monitoring equipment
The advanced technology integrated into fetal monitors comes at a heavy price. Sophisticated monitoring techniques such as Doppler ultrasound machines also incur hefty charges. The probes used in the Doppler technology (for example, the Philips Doppler transducer) range from USD 4,500 to USD 17,000. The SonoScape system from GE Healthcare costs around USD 9,000. These machines also incur maintenance charges, which amount to 15% of the unit's purchasing cost. The high costs of fetal monitoring equipment can be challenging to low-income nations and low-resource hospitals, thus restraining this market's growth.
OPPORTUNITY: Development of noninvasive, portable, and advanced fetal monitors
The key manufacturers in the market are expanding their product lines to include portable and wireless monitoring systems that are accurate, safe, and affordable. The key players in the market are also integrating telecommunication into these devices. For instance, Philips launched the handheld and tele-ultrasound solution, Lumify, in Japan and Avalon CL in the US in 2020. Similarly, the strategic collaboration between MindChild Medical and Henry Schein Medical expanded the MERIDIAN M110 Fetal Monitoring System's distribution and supply, a noninvasive intrapartum monitor in the US, in 2019.
“Ultrasound Devices is expected to hold the largest share of the fetal monitoring market, by product in 2021.”
Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. Ultrasound devices are the largest segment in this market. This segment's growth can primarily be attributed to technological advancements, increasing congenital anomalies, maternal mortality, and rising regulatory approvals.
“Non-portable systems are expected to hold the largest share of the fetal monitoring market, by portability in 2021.”
Based on portability, the market is segmented into non-portable systems and portable systems. In 2020, non-portable systems accounted for the largest share of this market, owing to wide applications in hospitals and diagnostic centers to assess fetal and maternal health.
“Noninvasive is expected to hold the largest share of the fetal monitoring market, by method in 2021.”
Based on the method, the market is segmented into invasive and noninvasive. In 2020, the noninvasive accounted for the largest share of this market. Noninvasive methods are widely accepted for their safer method of diagnosing and monitoring the fetus, especially in high-risk pregnancies. The rising approvals of various noninvasive monitoring devices and the incoming advanced technologies drive the growth of this segment.
“Antepartum is expected to hold the largest share of the fetal monitoring market, by application in 2021.”
Based on application, the market is segmented into antepartum and intrapartum. The antepartum segment accounts for the largest share of the fetal monitoring market. Antepartum fetal monitoring is carried out throughout the gestation period to diagnose any congenital fetal abnormalities. The extensive monitoring regimes, recent product launches, surging prevalence of fetal anomalies, and maternal mortalities drive the growth of the antepartum segment.
“Hospitals are expected to hold the largest share of the fetal monitoring market, by end user in 2021.”
The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2020, hospitals accounted for the largest share of this market. This segment's growth can be attributed to several factors, such as highly advanced facilities in hospitals and the increasing number of pregnancy procedures. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals, thus supporting market growth.
To know about the assumptions considered for the study, download the pdf brochure
“North America commanded the largest share of the fetal monitoring market in 2021.”
On the basis of region, the fetal monitoring market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2019, North America commanded the largest share of the fetal monitoring market. The large share of this market segment can be attributed to the presence of an established reimbufrsement structure coupled with availability of experts in the North American countries.
Key Market Players
The major players operating in this market are Cardinal Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), FUJIFILM SonoSite, Inc. (US), Natus Medical Incorporated (US), Huntleigh Healthcare Limited (UK), The Cooper Companies Inc. (US), CONTEC Medical Systems Co., Ltd. (China), EDAN Diagnostics, Inc. (China), Neoventa Medical AB (Sweden), Bionet Co., Ltd. (South Korea), Progetti Srl (Italy), TRISMED Co., Ltd. (Republic of Korea), ShenZhen Luckcome Technology Inc. (China), MedGyn Products, Inc (US), Dixion (Germany), Promed Group Co., Ltd. (Hong Kong), Advanced Instrumentations (US), BRAEL-Medical Equipment (Poland), GPC Medical (India), BISTOS (Korea), Mediana (Korea), Life Plus (India), ChoiceMMed (China), Trivitron Healthcare (India), Dott Medical Co. Ltd. (China), Monarch Meditech (India), and Shenzhen Comen Medical Instruments Co., Ltd. (China).
Scope of the Report
|
Report Metric |
Details |
|
Market Size Available for Years |
2019–2026 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2021–2026 |
|
Forecast Units |
Value (USD Billion) |
|
Segments Covered |
Product, portability, method, application, end user and region |
|
Geographies Covered |
North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (Japan, China, India, Australia, South Korea, and the RoAPAC), and Rest of the World (RoW) (Middle East & Africa and Latin America) |
|
Companies Covered |
Cardinal Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), FUJIFILM SonoSite, Inc. (US), Natus Medical Incorporated (US), Huntleigh Healthcare Limited (UK), The Cooper Companies Inc. (US), CONTEC Medical Systems Co., Ltd. (China), EDAN Diagnostics, Inc. (China), Neoventa Medical AB (Sweden), Bionet Co., Ltd. (South Korea), Progetti Srl (Italy), TRISMED Co., Ltd. (Republic of Korea), ShenZhen Luckcome Technology Inc. (China), MedGyn Products, Inc (US), Dixion (Germany), Promed Group Co., Ltd. (Hong Kong), Advanced Instrumentations (US), BRAEL-Medical Equipment (Poland), GPC Medical (India), BISTOS (Korea), Mediana (Korea), Life Plus (India), ChoiceMMed (China), Trivitron Healthcare (India), Dott Medical Co. Ltd. (China), Monarch Meditech (India) and Shenzhen Comen Medical Instruments Co., Ltd. (China). |
This research report categorizes the fetal monitoring market into the following segments and subsegments:
Fetal Monitoring Market by Product
- Ultrasound Devices
- 2D Ultrasound
- 3D & 4D Ultrasound
- Doppler Imaging
- Electronic Maternal/Fetal Monitors
- Uterine Contraction Monitors
- Internal Uterine Contraction Monitors
- External Uterine Contraction Monitors
- Fetal Electrodes
- Fetal Doppler Devices
- Telemetry Devices
- Accessories and Consumables
Fetal Monitoring Market by Portability
- Portable Systems
- Non-portable Systems
Fetal Monitoring Market by Method
- Invasive
- Noninvasive
Fetal Monitoring Market by Application
- Antepartum
- Intrapartum
Fetal Monitoring Market by End User
- Hospitals
- Obstetrics & Gynecology Clinics
- Home Care Settings
Fetal monitoring Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Rest of the World
- Latin America
- Middle East & Africa
Key developments:
- In 2020, Koninklijke Philips N.V. launched the Avalon CL Fetal and Maternal Pod and Patch in the US.
- In 2020, UroLift FUJIFILM SonoSite launched the SonoSite PX Ultrasound System in the US
- In 2019, Siemens Healthineers partnered with Braunschweig Municipal Hospital to provide high-quality and cost-effective medical care for patients
- In 2019, EDAN Diagnostics, Inc. established an American subsidiary called EDAN Diagnostic, Inc. (ED).
- In 2018, Trivitrion Healthcare collaborated with Investment Funds for Health in Africa (IFHA) to launch Trivitron Healthcare Africa B.V. (“THA”), a new medical technology company focused on the African continent. THA will provide high-quality medical devices and instruments with reliable after-sales service support across the country
- In 2018, GE Healthcare partnered with SonoSim to provide enhanced education services to new and existing ultrasound users globally.
Frequently Asked Questions (FAQ):
What are the growth opportunities in the fetal monitoring market across major regions in the future?
The development of noninvasive, portable, and advanced fetal monitors and emerging markets and strengthening infrastructure are anticipated to offer growth opportunities in the fetal monitoring market during the forecast period.
Which device is expected to hold the largest share in the fetal monitoring market?
The devices used for fetal monitoring include, ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. Ultrasound devices are used widely across the globe and its significant share can be attributed to technological advancements, increasing congenital anomalies, maternal mortality, and rising regulatory approvals.
Which end user is anticipated to hold a considerable share in the fetal monitoring market?
The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2020, hospitals accounted for the largest share of this market, owing to several factors, such as highly advanced facilities in hospitals and the increasing number of pregnancy procedures. Technological advancements, coupled with government funding, are also encouraging the installation of new tools and devices in hospitals, thus supporting market growth.
Which region has a well-developed fetal monitoring market?
Among the regions North America commanded the largest share of the fetal monitoring market. The large share of this market segment can be attributed to the presence of an established reimbufrsement structure coupled with availability of experts in the North American countries.
What is the impact of COVID-19 on fetal monitoring market?
The fetal monitoring market has been found to be minimally affected by the outbreak of COVID. The coronavirus pandemic has compelled regulatory bodies, such as the FDA, to ease their regulatory norms for fetal monitors to support the uninterrupted care regime of expectant mothers. Relaxations in rules have paved the way for several key players to smoothly launch fetal monitors equipped with tele-ultrasound monitoring, noninvasive features, and portable technologies. For instance, the FDA released its updated April 2020 FDA guidance amid the pandemic, under which Philips successfully launched its fetal monitor, Avalon CL, in the US on June 12, 2020. The FDA’s enforcement policy for noninvasive fetal and maternal monitoring devices aims to increase access to devices that could reduce the need for in-clinic visits and reduce the burden on doctor’s offices and hospitals during the pandemic.
On the other hand, the supply and sales operations of major companies in the market were affected in Q2 2020 due to the pandemic. However, operations resumed in Q3 as countries ended the lockdown and permitted the transportation of medical goods. These developments are anticipated to support the growth of the fetal monitoring market. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 FETAL MONITORING MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 LIMITATIONS
2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 APPROACH 3: PARENT MARKET ANALYSIS [NEONATAL CARE EQUIPMENT AND FETAL (LABOR & DELIVERY) MARKET]
FIGURE 6 APPROACH 4: PARENT MARKET ANALYSIS (ULTRASOUND MARKET)
FIGURE 7 APPROACH 5: PARENT MARKET ANALYSIS (HOME HEALTHCARE MARKET)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 ECONOMIC ASSESSMENT
2.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
3 EXECUTIVE SUMMARY (Page No. - 47)
FIGURE 13 FETAL MONITORING MARKET, BY PRODUCT, 2021 VS. 2026 (USD BILLION)
FIGURE 14 FETAL MONITORING MARKET, BY PORTABILITY, 2021 VS. 2026 (USD BILLION)
FIGURE 15 FETAL MONITORING MARKET, BY METHOD, 2021 VS. 2026 (USD BILLION)
FIGURE 16 FETAL MONITORING MARKET, BY APPLICATION, 2021 VS. 2026 (USD BILLION)
FIGURE 17 FETAL MONITORING MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
FIGURE 18 FETAL MONITORING MARKET, BY REGION, 2021 VS. 2026 (USD BILLION)
4 PREMIUM INSIGHTS (Page No. - 51)
4.1 FETAL MONITORING MARKET OVERVIEW
FIGURE 19 THE RISING NUMBER OF PRETERM BIRTHS IS A MAJOR FACTOR DRIVING THE GROWTH OF THE FETAL MONITORING MARKET
4.2 NORTH AMERICA FETAL MONITORING MARKET SHARE, BY PORTABILITY (2020)
FIGURE 20 NON-PORTABLE SYSTEMS TO DOMINATE THE NORTH AMERICAN MARKET IN 2020
4.3 GEOGRAPHICAL SNAPSHOT OF THE FETAL MONITORING MARKET
FIGURE 21 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 FETAL MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 The rising number of preterm births and the increasing adoption of infertility treatments
5.2.1.2 Advanced and innovative fetal monitoring technologies
5.2.1.3 Government initiatives and increasing collaborations for research by health agencies
5.2.1.4 Reimbursements and insurance policies for fetal monitoring services
TABLE 1 CPT CODES FOR VAGINAL DELIVERIES
5.2.1.5 Active product launches by key manufacturers
5.2.2 RESTRAINTS
5.2.2.1 High costs of fetal monitoring equipment
5.2.2.2 Availability of refurbished products
5.2.3 OPPORTUNITIES
5.2.3.1 Development of noninvasive, portable, and advanced fetal monitors
5.2.3.2 Emerging markets and strengthening infrastructure
5.2.4 CHALLENGES
5.2.4.1 Product recalls
TABLE 2 PRODUCT RECALLS IN THE FETAL MONITORING MARKET
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 23 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 24 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASES
5.5 ECOSYSTEM ANALYSIS
FIGURE 25 ECOSYSTEM ANALYSIS OF THE FETAL MONITORING INDUSTRY
5.5.1 ROLE IN THE ECOSYSTEM
5.6 REGULATORY LANDSCAPE
TABLE 3 LIST OF REGULATORY AUTHORITIES
5.6.1 EU REGULATIONS
5.6.2 US REGULATIONS
5.7 PORTER’S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 INTENSITY OF COMPETITIVE RIVALRY
5.7.5 THREAT OF SUBSTITUTES
5.8 COVID-19 IMPACT ANALYSIS ON THE FETAL MONITORING MARKET
5.9 PATENT ANALYSIS
5.9.1 UTERINE CONTRACTION MONITORS
5.9.2 FETAL DOPPLERS
5.9.3 FETAL ELECTRODES
5.10 TRADE ANALYSIS (ULTRASOUND)
5.10.1 IMPORT DATA FOR ULTRASOUND (VALUE), BY COUNTRY, 2017–2019 (USD MILLION)
5.10.2 EXPORT DATA FOR ULTRASOUND (VALUE), BY COUNTRY, 2017–2019 (USD MILLION)
5.10.3 EXPORT DATA FOR ULTRASOUND (VOLUME), BY COUNTRY, 2017–2019 (KILOGRAMS)
5.10.4 IMPORT DATA FOR ULTRASOUND (VOLUME), BY COUNTRY, 2017–2019 (KILOGRAMS)
5.11 TECHNOLOGY ANALYSIS
5.12 AVERAGE SELLING PRICE TREND
TABLE 4 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS
6 FETAL MONITORING MARKET, BY PRODUCT (Page No. - 72)
6.1 INTRODUCTION
TABLE 5 FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 ULTRASOUND DEVICES
TABLE 6 ULTRASOUND DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 7 ULTRASOUND DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1 2D ULTRASOUND
6.2.1.1 The increasing commercialization of innovative 2D technologies drives the growth of this segment
TABLE 8 FETAL MONITORING MARKET FOR 2D ULTRASOUND, BY REGION, 2019–2026 (USD MILLION)
6.2.2 3D & 4D ULTRASOUND
6.2.2.1 Technological advantages of 3D & 4D Ultrasound over 2D ultrasound to drive segment growth
TABLE 9 FETAL MONITORING MARKET FOR 3D & 4D ULTRASOUND, BY REGION, 2019–2026 (USD MILLION)
6.2.3 DOPPLER IMAGING
6.2.3.1 Doppler imaging analyzes fetal hemodynamics useful for fetal surveillance; key factor driving segment growth
TABLE 10 FETAL MONITORING MARKET FOR DOPPLER IMAGING, BY REGION, 2019–2026 (USD MILLION)
6.3 ELECTRONIC MATERNAL/FETAL MONITORS
6.3.1 THE RISING NUMBER OF HIGH-RISK PREGNANCIES AND THE REQUIREMENT OF ADVANCED FETAL MONITORING DEVICES TO ACCELERATE SEGMENT GROWTH
TABLE 11 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.4 FETAL ELECTRODES
6.4.1 THE NEED FOR INTRAPARTUM FETAL SURVEILLANCE TO SUPPORT THE MARKET GROWTH OF THIS SEGMENT
TABLE 12 FETAL ELECTRODES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.5 FETAL DOPPLER DEVICES
6.5.1 THE USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS TO DRIVE SEGMENT GROWTH
TABLE 13 FETAL DOPPLER DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.6 UTERINE CONTRACTION MONITORS
TABLE 14 UTERINE CONTRACTION MONITORS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 15 UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.6.1 INTERNAL UTERINE CONTRACTION MONITORS
6.6.1.1 The accurate measurement obtained by internal UCMs to propel segment growth
TABLE 16 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS
6.6.2.1 The noninvasive nature of external UCMs is a factor supporting market growth
TABLE 17 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.7 TELEMETRY DEVICES
6.7.1 THE BENEFIT OF REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES IS A MAJOR FACTOR DRIVING MARKET GROWTH
TABLE 18 TELEMETRY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.8 ACCESSORIES AND CONSUMABLES
6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO THE INCREASING UTILIZATION OF ACCESSORIES AND CONSUMABLES
TABLE 19 ACCESSORIES AND CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.9 OTHER PRODUCTS
TABLE 20 OTHER PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
7 FETAL MONITORING MARKET, BY PORTABILITY (Page No. - 85)
7.1 INTRODUCTION
TABLE 21 FETAL MONITORING MARKET, BY PORTABILITY, 2019-2026 (USD MILLION)
7.2 NON-PORTABLE SYSTEMS
7.2.1 TECHNOLOGICAL ADVANCEMENTS OF NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH
TABLE 22 NON-PORTABLE SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
7.3 PORTABLE SYSTEMS
7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS DRIVES THE MARKET GROWTH OF THIS SEGMENT
TABLE 23 PORTABLE SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
8 FETAL MONITORING MARKET, BY METHOD (Page No. - 88)
8.1 INTRODUCTION
TABLE 24 FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
8.2 NONINVASIVE METHOD
8.2.1 NONINVASIVE METHODS ARE WIDELY ADOPTED IN HIGH-RISK PREGNANCIES, THUS DRIVING MARKET GROWTH
TABLE 25 NONINVASIVE MARKET, BY REGION, 2019–2026 (USD MILLION)
8.3 INVASIVE METHOD
8.3.1 CONSISTENT TRANSMISSION OF THE FETAL HEART RATE VIA INVASIVE METHODS SUPPORTS MARKET GROWTH
TABLE 26 INVASIVE MARKET, BY REGION, 2019–2026 (USD MILLION)
9 FETAL MONITORING MARKET, BY APPLICATION (Page No. - 92)
9.1 INTRODUCTION
TABLE 27 FETAL MONITORING MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
9.2 ANTEPARTUM
9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH OF THIS SEGMENT
TABLE 28 ANTEPARTUM MARKET, BY REGION, 2019–2026 (USD MILLION)
9.3 INTRAPARTUM
9.3.1 FAVOURABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH OF THE SEGMENT
TABLE 29 INTRAPARTUM MARKET, BY REGION, 2019–2026 (USD MILLION)
10 FETAL MONITORING MARKET, BY END USER (Page No. - 96)
10.1 INTRODUCTION
TABLE 30 FETAL MONITORING MARKET, BY END USER, 2019-2026 (USD MILLION)
10.2 HOSPITALS
10.2.1 THE AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE DRIVES SEGMENT GROWTH
TABLE 31 FETAL MONITORING MARKET FOR HOSPITALS, BY REGION, 2019–2026 (USD MILLION)
10.3 OBSTETRICS & GYNECOLOGY CLINICS
10.3.1 THE RISING EMPHASIS ON PERINATAL CARE TO BOLSTER THE GROWTH OF THIS SEGMENT
TABLE 32 FETAL MONITORING MARKET FOR OBSTETRICS & GYNECOLOGY CLINICS, BY REGION, 2019–2026 (USD MILLION)
10.4 HOME CARE SETTINGS
10.4.1 REMOTE-BASED CARE BY PORTABLE FETAL MONITORING SYSTEMS DRIVES THE GROWTH OF THIS END-USER SEGMENT
TABLE 33 FETAL MONITORING MARKET FOR HOME CARE SETTINGS, BY REGION, 2019–2026 (USD MILLION)
11 FETAL MONITORING MARKET, BY REGION (Page No. - 101)
11.1 INTRODUCTION
TABLE 34 FETAL MONITORING MARKET, BY REGION, 2019–2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT
TABLE 35 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 37 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.1 US
11.2.1.1 The US held the largest share of the North American market in 2020
TABLE 43 ULTRASOUND CPT CODES (2019)
TABLE 44 US: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 45 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 46 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 47 US: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 48 US: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 49 US: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 50 US: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Growing government initiatives for fetal and maternal care to drive the market growth in Canada
TABLE 51 CANADA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 52 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 53 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 54 CANADA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 55 CANADA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 56 CANADA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 57 CANADA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3 EUROPE
TABLE 58 EUROPE: FETAL MONITORING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Increasing healthcare expenditure to support market growth in Germany
TABLE 66 GERMANY: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 70 GERMANY: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 71 GERMANY: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 72 GERMANY: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2 UK
11.3.2.1 The rising emphasis towards better maternity services to drive market growth in the UK
TABLE 73 UK: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 74 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 UK: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 77 UK: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 78 UK: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 79 UK: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Increasing focus on healthcare policies to accelerate market growth during the forecast period
TABLE 80 FRANCE: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 81 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 83 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 84 FRANCE: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 85 FRANCE: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 86 FRANCE: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Increasing healthcare expenditure to propel the growth of the fetal monitoring market in Italy
TABLE 87 ITALY: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 ITALY: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 91 ITALY: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 92 ITALY: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 93 ITALY: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Declining birth rate to restrain the growth of the market during the forecast period
TABLE 94 SPAIN: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 95 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 98 SPAIN: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 99 SPAIN: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 100 SPAIN: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.6 REST OF EUROPE
TABLE 101 ROE: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 102 ROE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 ROE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 ROE: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 105 ROE: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 106 ROE: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 107 ROE: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT
TABLE 108 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 109 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Increasing focus on the launch of innovative products to propel market growth in Japan
TABLE 116 JAPAN: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 117 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 120 JAPAN: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 121 JAPAN: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 122 JAPAN: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Developing healthcare infrastructure in China to support market growth
TABLE 123 CHINA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 124 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 CHINA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 127 CHINA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 128 CHINA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 129 CHINA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.3 INDIA
11.4.3.1 The growing number of preterm births drives the market growth in India
TABLE 130 INDIA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 131 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 INDIA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 134 INDIA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 135 INDIA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 136 INDIA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.4 SOUTH KOREA
11.4.4.1 Increasing awareness for the implementation of ultrasound technology to drive market growth in South Korea
TABLE 137 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 138 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.5 AUSTRALIA
11.4.5.1 Rising emphasis on maternal care to bolster market growth in Australia
TABLE 144 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 145 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 149 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 150 AUSTRALIA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.6 REST OF ASIA PACIFIC
TABLE 151 ROAPAC: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 152 ROAPAC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 ROAPAC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 154 ROAPAC: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 155 ROAPAC: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 156 ROAPAC: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 157 ROAPAC: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5 REST OF THE WORLD
TABLE 158 REST OF THE WORLD: FETAL MONITORING MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 159 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 160 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5.1 MIDDLE EAST & AFRICA
11.5.1.1 A large number of pre-term births recorded in the MEA market drives the market growth in this region
TABLE 166 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 167 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 168 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 170 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 171 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 172 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5.2 LATIN AMERICA
11.5.2.1 Favorable government policies to support the growth of the market
TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2019–2026 (USD MILLION)
TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2019–2026 (USD MILLION)
TABLE 177 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD, 2019–2026 (USD MILLION)
TABLE 178 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 179 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER, 2019–2026 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 159)
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES
FIGURE 28 MARKET EVOLUTION MATRIX: JANUARY 2018 TO FEBRUARY 2021
12.3 MARKET SHARE ANALYSIS
FIGURE 29 FETAL MONITORING MARKET SHARE, BY KEY PLAYERS, 2019
12.4 COMPETITIVE EVALUATION MATRIX
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE
12.4.4 PARTICIPANTS
FIGURE 30 FETAL MONITORING MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)
12.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS AND SMES)
12.5.1 PROGRESSIVE COMPANIES
12.5.2 STARTING BLOCKS
12.5.3 RESPONSIVE COMPANIES
12.5.4 DYNAMIC COMPANIES
FIGURE 31 FETAL MONITORING MARKET: VENDOR DIVE MATRIX FOR SMES AND START-UPS, 2019
12.6 COMPANY PRODUCT FOOTPRINT
12.7 COMPANY GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE FETAL MONITORING MARKET
FIGURE 33 GEOGRAPHIC REVENUE MIX: FETAL MONITORING MARKET (2019)
12.8 COMPETITIVE SCENARIO
13 COMPANY PROFILES (Page No. - 171)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
13.1 KEY PLAYERS
13.1.1 GE HEALTHCARE
TABLE 184 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 34 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
13.1.2 SIEMENS HEALTHINEERS
TABLE 185 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 35 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
13.1.3 CARDINAL HEALTH, INC.
TABLE 186 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 36 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
13.1.4 KONINKLIJKE PHILIPS N.V.
TABLE 187 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
13.1.5 FUJIFILM SONOSITE, INC.
TABLE 188 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW
FIGURE 38 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
13.1.6 HUNTLEIGH HEALTHCARE LIMITED
TABLE 189 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW
FIGURE 39 ARJO: COMPANY SNAPSHOT
13.1.7 NATUS MEDICAL INCORPORATED
TABLE 190 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW
FIGURE 40 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
13.1.8 THE COOPER COMPANIES INC.
TABLE 191 THE COOPER COMPANIES INC.: BUSINESS OVERVIEW
FIGURE 41 THE COOPER COMPANIES INC.: COMPANY SNAPSHOT
13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD
TABLE 192 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
13.1.10 EDAN DIAGNOSTICS, INC.
TABLE 193 EDAN DIAGNOSTICS, INC.: BUSINESS OVERVIEW
13.2 OTHER PLAYERS
13.2.1 NEOVENTA MEDICAL AB
TABLE 194 NEOVENTA MEDICAL AB: BUSINESS OVERVIEW
13.2.2 BIONET CO., LTD
TABLE 195 BIONET CO., LTD.: BUSINESS OVERVIEW
13.2.3 PROGETTI SRL
TABLE 196 PROGETTI SRL: BUSINESS OVERVIEW
13.2.4 TRISMED CO., LTD.
TABLE 197 TRISMED CO., LTD.: BUSINESS OVERVIEW
13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC.
TABLE 198 SHENZHEN LUCKCOME TECHNOLOGY INC.: BUSINESS OVERVIEW
13.2.6 MEDGYN PRODUCTS, INC.
TABLE 199 MEDGYN PRODUCTS, INC. BUSINESS OVERVIEW
13.2.7 DIXION
TABLE 200 DIXION: BUSINESS OVERVIEW
13.2.8 PROMED GROUP CO., LTD.
TABLE 201 PROMED GROUP CO., LTD.: BUSINESS OVERVIEW
13.2.9 ADVANCED INSTRUMENTATIONS
TABLE 202 ADVANCED INSTRUMENTATIONS: BUSINESS OVERVIEW
13.2.10 BRAEL-MEDICAL EQUIPMENT
TABLE 203 BRAEL-MEDICAL EQUIPMENT: BUSINESS OVERVIEW
13.2.11 GPC MEDICAL LTD.
TABLE 204 GPC MEDICAL: BUSINESS OVERVIEW
13.2.12 MONARCH MEDITECH
TABLE 205 MONARCH MEDITECH: BUSINESS OVERVIEW
13.2.13 BISTOS CO., LTD.
TABLE 206 BISTOS CO., LTD.: BUSINESS OVERVIEW
13.2.14 MEDIANA CO., LTD
TABLE 207 MEDIANA CO., LTD: BUSINESS OVERVIEW
13.2.15 LIFE PLUS MEDICAL
TABLE 208 LIFE PLUS MEDICAL: BUSINESS OVERVIEW
13.2.16 CHOICEMMED
TABLE 209 CHOICEMMED: BUSINESS OVERVIEW
13.2.17 TRIVITRON HEALTHCARE
TABLE 210 TRIVITRON HEALTHCARE: BUSINESS OVERVIEW
13.2.18 DOTT MEDICAL CO. LTD
TABLE 211 DOTT MEDICAL CO. LTD.: BUSINESS OVERVIEW
13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
TABLE 212 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 218)
14.1 INDUSTRY INSIGHTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
The study involved four major activities to estimate the current size of the fetal monitoring market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Primary Research
Several stakeholders such as fetal monitoring manufacturers, vendors, distributors, researchers, and doctors from hospitals and clinics were consulted for this report. The demand side of this market is characterized by significant use of fetal monitoring due to the escalating prevalence of preterm births, favorable government policies, advanced technologies of fetal monitoring systems. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the fetal monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the fetal monitoring industry.
Report Objectives
- To define, describe, and forecast the fetal monitoring market on the basis of product, portability, method, application, end user, and region.
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities, Covid-19 Impact Analysis)
- To strategically analyse micromarkets with respect to individual growth trends, prospects, and contributions to the overall fetal monitoring market
- To analyse market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments in four geographical regions, namely, North America, Europe, the Asia Pacific, and Rest of the World.
- To profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies.
- To track and analyse competitive developments such as product launches and approvals, partnerships, expansions, and acquisitions in the fetal monitoring market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Geographic Analysis: Further breakdown of the fetal monitoring market into specific countries/regions in the Rest of Europe and the Rest of Asia Pacific.
- Company Information: Detailed analysis and profiling of additional market players (up to 3) inclusive of:
- Business Overview
- Financial Information
- Product Portfolio
- Developments (last three years)
Get in-depth analysis of the COVID-19 impact on the Fetal Monitoring Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Fetal Monitoring Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Fetal Monitoring Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Fetal Monitoring Market